BOSTON and LONDON, April 23, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today announced that it has commenced an underwritten public offering of $100 million of American Depositary Shares (“ADSs”), each representing one ordinary share. All of the ADSs are being offered by Centessa. In addition, Centessa intends to grant the underwriters a 30-day

ROCKVILLE, Md., April 23, 2024 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”) announced today that it received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) due to the Company not filing its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “Form 10-K”). Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all periodic reports with

First and only FDA-approved type II RAF inhibitor for patients with relapsed or refractory pLGG harboring a BRAF fusion or rearrangement, or BRAF V600 mutation RAPNO LGG overall response rate (ORR) of 51% Day One receives rare pediatric disease priority review voucher Conference call and webcast to be April 24, 8:30 a.m. Eastern Time BRISBANE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN) (“Day One” or the “Company”), a commercial-stage bi

NEW YORK, April 23, 2024 /PRNewswire/ -- Summer Health, a digital health company offering 24/7 pediatric support to parents, announced $11.65M in Series A Funding, co-led by new investor 7wire Ventures and returning investor Lux Capital. Returning investors Sequoia Capital, Metrodora Ventures, Box Group, and Shrug Capital participated, with new participation from Pivotal Ventures, a Melinda French Gates company and Leaps by Bayer. Alfred Lin of Sequoia Capital, Deena Shakir of Lux Capital, Alyss

Approval based on NETTER-P trial in which Lutathera demonstrated a consistent safety profile and comparable drug exposure between pediatric (ages 12-17) and adult patients Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a rare cancer that is often unresectable and commonly diagnosed in the late stages of disease Novartis, a leader in radioligand therapy (RLT), is investigating a portfolio of RLTs to treat a broad range of cancers, including GEP-NETs, lung, prostate, breast, colon, br

GE HealthCare has partnered with radiation therapy company Elekta to develop new software to improve clinicians experience and enable greater precision treatment. Elekta will use GE HealthCare’s MIM Software imaging management platform, which GE HealthCare acquired earlier this month. MIM’s auto contouring and treatment management platform will allow Elekta to develop radiation oncology treatments. "Our decision to join GE HealthCare was driven by a ‘shared vision of maximizing impact’ and our

23 April 2024Announcement no. 9 Grant of Warrants COPENHAGEN, DENMARK and BOSTON, MA, USA, April 23, 2024 (GLOBE NEWSWIRE) – The Board of Directors of BioPorto A/S (“BioPorto” or the “Company”) (CPH:BIOPOR) has resolved, in accordance with the annual general meeting’s resolution on April 27, 2023, to issue a total of 4,000,000 warrants to members of the Executive Management. Each warrant grants the holder the right to subscribe for one share in BioPorto. The exercise price is DKK 1.

Patient-management company ABOUT Healthcare announced it has acquired AI analytics platform Edgility, enabling ABOUT to offer patient progression solutions with predictive and prescriptive analysis. ABOUT Healthcare, formerly Central Logic, provides a product-care suite that allows it to move patients in and out of various settings, such as acute care and home-based care. Edgility’s AI solution uses forecasting of discharge goals to provide real-time metrics that allow more efficient patient p

FAA-approved drone technology will accelerate response to 9-1-1 callers in Manatee County coverage area. Video Link: TAMPA, Fla., April 23, 2024 /PRNewswire/ -- As part of Tampa General Hospital's (TGH) commitment to transforming health care through innovation, the academic health system collaborated with Manatee County and Archer First Response Systems (ArcherFRS) to accelerate response times to health-related emergencies with drone delivery. The 9-1-1 integrated drone delivery system sponsore

In vivo creation of autologous CAR cells after a single intravenous administration of an off-the-shelf targeted vector and formal GLP toxicology data support clinical entry in 2024 Company to deliver 3 oral and 3 poster presentations highlighting its portfolio of in vivo CAR data in oncology and autoimmunity programs PHILADELPHIA, April 23, 2024 /PRNewswire/ -- Interius BioTherapeutics, a leading developer of in vivo cell-specific gene medicines, today announced the presentation of preclinical d